Ingancin Peptide Reagent don Binciken Brain-Penetrant NLRP3

Abubuwan da ake bukata: Abin da kuke Bukata Kafin Ka Fara

Tafsirin Peptide CoA yana farawa da takardu, ba pipettes. Yi waɗannan abubuwa biyar a hannu kafin ku cancanci wani abu:

• Takamaiman takaddun shaida na bincike da aka ɗaure da daidaitaccen tsari guda ɗaya. Takaddun ya kamata ya ba da rahoton ainihi ta MS tare da lura da yawan ka'idoji a cikin ƙayyadaddun haƙuri, Tsaftar HPLC tare da chromatogram da teburin haɗin kai, counterion ainihi, endotoxin a cikin EU / MG tare da tushen assay mai suna (LAL ko rFC), da yanayin hanyar nazari: shafi, mobile lokaci da gradient, yawan kwarara, tsinkayar zango (Ina Q2(R2), 2023-11-30).

  

• Raw MS da HPLC fayilolin bayanai, ba kawai shafin taƙaitawa ba, don haka ana iya sake gina rikodin daga baya.

• Sakamakon endotoxin da aka ɗaure da samfurin za ku gwada da gaske, ba ga dan uwa da yawa.

• Log ɗin kulawa rufe kwanan watan karɓa, zafin jiki na ajiya, da kowane narke, bi Ka'idodin amincin bayanan ALCOA (MHRA, 2018-03): m, m, na zamani, asali, m.

  

• Ƙirƙirar buffer assay, an rubuta, gami da kashi na DMSO na ƙarshe.

Lokaci, Wahala, da Ilimin da aka dauka

Kasafin kudin sa'o'i biyu zuwa hudu na yawa daya tare da cikakkun takardu, ya daɗe idan kuna buƙatar tabbatarwa ta orthogonal ko kun cancanci kuri'a da yawa lokaci guda. Wahala shine matsakaici. Ya kamata ku kasance cikin kwanciyar hankali karanta chromatograms na RP-HPLC da teburin haɗin kai, duba tabbacin taro na MS akan ƙimar ka'idar, da fassara LAL ko rFC rahoton endotoxin.

Mataki 1: Tabbatar da Tsarin Peptide Fidelity Bayan Tsaftar Ƙa'ida

A ƙarshen wannan mataki za ku tabbatar da cewa jerin peptide, ba kawai tsarkinta na chromatographic ba, yayi daidai da tsarin da aka nufa. Wani adadi mai tsabta na ≥95% na HPLC yana kwatanta adadin mafi girman yanki shine peptide, ba wanda peptide ne, kuma su biyun suna tafe akai-akai.

Share peptides da aka samu ta hanyar haɗakarwa mara cika sune mafi yawan ajin ƙazanta masu alaƙa da tsari a cikin Fmoc SPPS., yawanci suna kasancewa a matakin kashi-zuwa-ƙasa a cikin ɗanyen abu kuma da wahala a rarrabe saboda sun bambanta da wayo kawai daga manufa. (Cell-Peptide, Daga Jeri zuwa Vial: Al'ada Peptide Synthesis, 2026-07-13). Trifluoroacetate lamari ne na daban gaba ɗaya: juriya ne maimakon rashin tsarkin tsari, don haka bai taba nuna jerin kuskure ba, amma yana canza abun cikin peptide net, bayyananniya taro da kuma wani lokacin riƙe hali, wanda ke nufin dole ne a gyara shi kafin ku lissafta yawan adadin (Zuwa Ijma'i don Bincike da Musanya TFA, 2025-08).

Wurin tabbatarwa: yawan abin da aka lura da yawa ya dace da ka'idar a cikin haƙurin da aka bayyana kuma kun yi rikodin abun ciki daban da abun cikin peptide.

Karanta Tabbacin MS da Filayen Ƙaddamarwa

Fara da abin lura-da-ka'idar ka'ida ta nau'i-nau'i da juriya na jihohi masu kaya. Wani wasa a cikin wannan taga yana tabbatar da rinjayen nau'in; ba ya ware ƙazanta na isobaric mai haɗin gwiwa wanda ke faruwa da ionise a daidai wannan m/z.

Abubuwan da ke cikin Counterion shine inda fassarar peptide CoA galibi ke yin kuskure. A cikin ingantaccen abun ciki na TFA da binciken musanya, salts peptide salts dauke da TFA- har zuwa kusan 35% (w/w), tare da auna ma'auni na 0.333 ± 0.008 MG TFA- da MG peptide gishiri kafin musanya, a kan kewayon stoichiometric da ake tsammani na kusan 22-29% (w/w) dangane da caji (Zuwa Ijma'i don Bincike da Musanya TFA, 2025-08). Idan yawan adadin ku ya fito daga nauyin peptide mara kyau, wannan gibin ya sauka kai tsaye a cikin tunanin ku.

Don Tukwici: Gyara abun ciki na jujjuyawa kafin kididdige yawan ƙididdiga. Idan kuri'a tana buƙatar musanya, Haka binciken ya gano cewa zagayowar guda ɗaya 10 mM HCl musayar ya rage TFA- ƙasa da iyakar ƙididdige duk hanyoyin uku da aka gwada (<1% w/w) yayin da tsarki ya rike a sama 96% (Zuwa Ijma'i don Bincike da Musanya TFA, 2025-08). Kula da iyaka: RP-HPLC na yau da kullun da MS-mataki ɗaya na iya rasa ƙazantattun isobaric, don haka bi da tsaftataccen sawu biyu kamar yadda ya cancanta amma bai wadatar ba.

Lokacin Neman Taswirar Peptide ko LC-MS/MS

Haɓaka zuwa hanyar orthogonal lokacin da jerin ke ɗauke da isomerization-prone ko racemization-prone rago, ko lokacin da karatun nazarin halittu ya yi ƙarfi ba zato ba tsammani don adadin da kuka yi imani da ku. Dalilin dalili shine matsalar haɗin gwiwa: jeri masu alaƙa da suka bambanta da saura ɗaya na iya zama ƙarƙashin kololuwa ɗaya, don haka chromatogram ba zai iya raba su ba komai yadda aka saita haɗin kai (Cell-Peptide, 2026-07-13). Taswirar Peptide ko LC-MS/MS suna warware jerin da kanta maimakon kololuwa.

Mataki 2: Sarrafa Tarukan Peptide a cikin Binciken CNS

A karshen wannan mataki, za ku bincika kuri'ar ku don tarin abubuwan da aka riga aka yi kuma ku share su ba tare da yin shiru ba ku canza adadin da kuke bayarwa ga tantancewar..

Me yasa Lipophilic Brain-Penetrant Seques Seques Abone Kai

Haɗa baya buƙatar dalili na musamman. A 2006 nazarin Aβ42 hydrophobicity da jerin-dogara aggregation ya nuna cewa generic hydrophobicity ya isa ya fitar da tarawa: hydrophobic mikewa, ko tsakiya ko C-terminal, na iya haifar da fibrils, helix daure, ko rikice rikice, sau da yawa suna wucewa ta tsaka-tsakin ruwa-ruwa ko amorphous kafin kowane fibril da aka ba da oda ya bayyana.

Wannan gano yana da mahimmanci a nan saboda ƙira-ƙwaƙwalwar ƙira tana tura jeri a daidai wannan hanyar. Bayyanar CNS yana son halayen lipophilic, don haka dukiyar da ke sa peptide mai amfani ita ce dukiyar da ke sa ta tara. "Jerin mu ba shi da wani abin da aka sani game da tarawa" don haka ba dalili ba ne don tsallake allon..

Share Abubuwan Taɗi Ba tare da Rasa Adadin ku ba

Guda gwajin tarawar orthogonal kafin tantancewa. Thioflavin T ya ba da rahoton amyloid-kamar fibrils, watsawar haske mai tsauri yana ba da rahoton rarraba girman-ɓangarorin da kuma canjin radius na hydrodynamic, kuma turbidity yana ba da allon watsawa mai sauri. Lokacin da sigina ya bayyana, share kayan ta 0.22 µm tacewa ko centrifugation.

Sannan sake duba maida hankali. Tace iya cire peptide tare da aggregates, don haka taceccen haja na iya daina yin daidai da maida hankali akan lakabin. Babu wata ƙa'ida ta duniya da ta yi hasashen waɗanne jeri za su tara, wanda shine dalilin da yasa allon yana da tasiri maimakon tsinkaya.

Mataki 3: Tabbatar da Solubility na Peptide a cikin CSF-Mimetic Buffer

A ƙarshen wannan matakin za ku sami rubutaccen kashi mai narkewa a cikin ainihin ma'aunin tantancewa, ba na suna ba. Peptide solubility a cikin CSF-mimetic buffer shine ƙimar da aka auna na yawan ku a cikin matrix ɗin ku, kuma tazarar da ke tsakanin adadin da aka auna da kuma narkar da shi shine inda yawancin kurakuran halayen CNS suka fara..

Shirya babban haja a cikin DMSO, sai a zuba shi a hankali a juye a cikin wani lokaci mai zuga ruwa maimakon bututun shi a matsayin bolus. Jagorar mai siyarwa akan shirye-shiryen hannun jari na DMSO yana ba da shawarar amfani da aliquots guda ɗaya da ƙarancin DMSO na ƙarshe, kuma yana ɗaukar turɓayar da ake gani a matsayin alamar faɗakarwa (Sigma-Aldrich jagorar fasaha; lura cewa wannan jagorar mai siyarwa ce, kuma masu siyar da kayan kaushi da reagent suna da sha'awar kasuwanci a cikin ayyukan kulawa da suke ba da shawarar). Idan mafita ga girgije, kashi mai narkewa yana ƙasa da maras muhimmanci, duk abin da takardar shaidar bincike ta bayyana.

Abubuwan Buffer da Rufin DMSO

Daidaita ma'ajin da gwajin da za ku yi aiki da gaske, kuma yi rikodin abun da ke ciki tare da lambar kuri'a. Tsarin CSF-mimetic na gama gari sun haɗa da CSF wucin gadi da aka gina akan bicarbonate ko tushe HEPES, da phosphate-buffered saline gyara don pH da ionic ƙarfi. Kowannensu ya bambanta da yadda yake jurewa haɗin kai, don haka rufin dukiya ne na assay, ba tsayayyen lamba ba.

Don tsarin tushen tantanin halitta, DMSO taro na ƙarshe na 1% ko ƙasa shine iyakar aiki gama gari, kuma kididdigar cewa ya kamata a yi haƙuri da ƙasa zuwa rufi mai tsauri. Madaidaicin rufi ya bambanta ta hanyar tantancewa da tushe, don haka kafa shi don karantawa na kanku maimakon shigo da lamba daga wata yarjejeniya.

⚠️ Gargadi: Turbidity yana nufin ainihin adadin mai narkewa yana ƙasa da na ƙima. Kada a ba da rahoton adadin da aka auna azaman taro da aka kawo.

Daskare-Thaw Ladabi da Yin Amfani Guda Daya

Yin amfani da guda ɗaya shine rage haɗari, ba doka mai wahala ba. A cikin binciken daskare-narkewar damuwa mai sarrafawa, samuwar barbashi mai iya aunawa ya bayyana ta hanyar zagayowar kusan guda biyar a wasu jarin furotin da aka buffer (BSA da β-galactosidase, hawan keke tsakanin -80 ° C da 25 °C za 20 mintuna kowanne a ciki 100 mM sodium phosphate), yayin da wasu ƙananan ƙwayoyin cuta ba su nuna asara ba bayan zagayowar goma sha ɗaya (daskare-narke samuwar barbashi a cikin hannun jari masu buffered, 2024 pre-hujja). Wannan shaidar ta fito ne daga hannun jari na furotin maimakon peptides, kuma babu iyaka zagayowar duniya, don haka yi la'akari da binciken a matsayin dalilin da za a yi la'akari da ra'ayin mazan jiya maimakon a matsayin kofa da za ku iya dogara da ita..

Mataki 4: Cancantar Endotoxin don Ingantaccen Reagent Peptide a cikin Binciken Kwakwalwa-Penetrant NLRP3

A ƙarshen wannan mataki za ku sami sakamakon endotoxin da aka bayyana a cikin raka'a da aka ɗaure da samfurin da kuka gwada a zahiri, tare da tushen tantancewa da dawo da karu tare da rubuce tare da shi. Wannan shine mafi ƙarancin da ake buƙata don jayayya cewa peptide bai ba da gudummawa ga karatun ku na kumburi ba.

Me yasa Rahoto / Rashin Rahoton Endotoxin ya kasa Binciken CNS

“Masu wucewa” akan takardar shaidar bincike yana gaya muku sakamakon ya faɗi ƙarƙashin iyaka da wani aka saita don wata manufa ta daban. Ba ya gaya maka nawa endotoxin ke cikin vial, don haka ba za a iya juyar da shi zuwa maida hankali a cikin rijiyar ku ko dabbar ku ba.

Wannan gibin yana da mahimmanci saboda microglia suna jin daɗin LPS sosai, da LPS priming wanda ke biye da abin motsa jiki na biyu kamar nigericin a shirye yake samar da kunnawar NLRP3 na canonical.. gurɓataccen peptide na CNS na iya haifar da cikakke, gamsarwa mai ƙoshin ƙoshin lafiya ba tare da gudummawa daga jerin peptide kanta ba.

Hakanan yana da wahala a gano cutar a cikin bayanan ku. LPS priming wanda baya buƙatar sabon furotin NLRP3 ya kasance mai aunawa a gajeriyar lokutan kafin magani kuma ya ci gaba da kasancewa Nlrp3-/- macrophages da aka sake gina su tare da mai gabatarwa. Babu sa hannun rubutun da ya bayyana da ya nuna alamarsa.

Sakamako Masu Daure Raka'a, Karu farfadowa, da Ƙarƙashin Ƙarƙashin Endotoxin

Nemi sakamakon a cikin EU/MG, daura da samfurin da aka gwada, kuma ga assay assay bayan shi. USP <85> gwajin endotoxins na kwayan cuta yana buƙatar LAL reagent mai lakabin azanci ba ƙasa da 0.15 EU/ml, tare da iyakoki da aka saita a kowane ɗaya ko ta tsarin K/M kuma an bayyana shi azaman EU/ml, EU/mg ko EU/unit. Wannan bene na kyauta yana zaune sama da abin da aikin CNS ke buƙata.

Tsarukan bincike-tsara sun kai ƙasa. Kwatanta LAL da bayanan ji na rFC sanya adadin kusa 0.005 EU/ml don rFC da 0.01 EU/ml don wasu tsarin LAL. Maƙasudin tsafta da aka saba amfani da shi don masu samar da peptide a cikin tushen tantanin halitta kuma a cikin vivo aikin CNS yana ƙarƙashin 0.1 EU/ml ko kasa 1 EU/mg. Ɗauki wannan adadi azaman maƙasudin ma'aikaci, ba iyaka ba. FDA ta 0.06 Ƙofar EU/ml don na'urori masu tuntuɓar CSF kwatankwacin lamba-ruwa ne kawai, ba wani takamaiman peptide ba.

Maidowa karu yana rufe madauki. Idan ba tare da shi ba ba za ku iya sanin ko matrix ɗin ya danne gwajin kuma ya samar da ƙarancin ƙima.

Key Takeaway: Sakamakon endotoxin yana da amfani kawai idan an bayyana shi a cikin raka'a da aka ɗaure da samfurin da aka gwada, tare da tushen tantancewa da kuma bayanan dawo da karu.

Mataki 5: Kulle Takardun Lutu da Ganowa

Ayyuka A ƙarshen wannan matakin zaku riƙe takamaiman takamaiman rikodin wanda za'a iya sake ginawa bayan watanni, bayan mutumin da ya gudanar da binciken ya ci gaba kuma asalin imel ɗin ya ɓace.

Takaddun shaida na bincike mai suna kawai lambar kasida ba ya yin wannan. Abin da kuke buƙata shine takarda da aka ɗaure da daidaitaccen tsari guda ɗaya, kuma filayen da suke sanya shi yin lodi su ne wadanda mutane ke tsallakewa idan sun karanta da sauri.

Abin da Yakamata Kunshin Nazari Na Musamman Ya ƙunshi

Takamaiman takaddun shaida na bincike yakamata yayi rahoto, don wannan rukunin kawai: Asalin MS tare da lura da taro na ka'ida da kuma fayyace haƙuri, Tsaftar HPLC tare da chromatogram da teburin haɗin kai, counterion ainihi, endotoxin a cikin EU / MG tare da tushen assay mai suna, da yanayin hanyar nazari (shafi, mobile lokaci da gradient, yawan kwarara, tsinkayar zango). Kowane filin yana amsa tambayar gazawa daban-daban. Mass yana tabbatar da jerin; teburin haɗin kai yana nuna ko adadi mai tsabta ya fito ne daga kololuwa mai tsabta ko kafada; counterion yana gaya muku abin da ke cikin vial; EU/mg yana danganta lambar endotoxin zuwa kashi wanda zaku iya ƙididdigewa.

Fassarar Peptide CoA ita ce inda yawancin labs ke rasa lokaci, saboda tsaftar kashi ba tare da chromatogram ɗin sa ba. Abokin haɗin gwiwa tare da HPLC/MS na cikin gida da sterility QC na iya ba da takamaiman fakitin nazari wanda ke rufe waɗannan filayen., wanda ke taimakawa lokacin da kuke buƙatar yanayin yanayin ɗanyen maimakon layin taƙaitawa.

Haɗarin Bayar da Haɗari Tsakanin Nazarin Watanni da yawa

Nazarin da ke gudana na tsawon watanni zai yiwu ya haye kuri'a, kuma tsallakawa yawanci ba a gani: sabuwar vial ta iso, lakabin yayi kama da haka, kuma babu wanda ya rubuta cewa mai gano tsari ya canza.

Rikodi a karatu fara mai gano tsari, da nazari kunshin bita, da kwanan wata kowace vial ta shiga firiza. Sannan a yi amfani da ka'idodin amincin bayanan ALCOA zuwa log ɗin reagent kanta: m, m, na zamani, asali, m, tare da danyen bayanai da lissafin da aka adana tare da shigarwa. Idan an shigar da canjin tsakiyar karatu kamar yadda ya faru, Ana iya bincika canjin martani akan rikodin reagent maimakon yin gardama game da gaba. Matsakaicin adadin-zuwa-yawan Peptide ba wani abu bane da zaku iya ɗauka daga sunan mai kaya; wani abu ne na log ɗin ku ko dai takardu ko bai yi ba.

Mataki 6: Alamar ƙira da Gudanarwa da Gyara

A karshen wannan mataki, za ku sami saitin sarrafawa wanda ke raba tasirin lakabi daga tasirin peptide, don haka ba za a iya kuskuren karantawa mai kyalli ko kusanci da na halitta ba.

Lokacin da Alamar Canza Gwajin

Alamar kyalli ko alamar alaƙa shine gyare-gyaren sinadarai, ba mai lura da tsaka-tsaki ba. Haɗa babban fluorophore ko abin hannun biotin yana canza nauyin kwayoyin halitta, lipophilicity da rarraba caji, kuma waɗancan kaddarorin suna sarrafa iko, solubility na ruwa mai ruwa da kuma halayen shingen jini-kwakwalwa. peptide mai lakabin wanda ke rarrabuwa daban da reagent mara lakabi na iya nuna bayyanar CNS da aka canza a daidai gwargwado iri ɗaya., wanda ke nufin analog mai lakabin ba ta atomatik maye gurbin wanda ba shi da lakabi.

Wannan shine mafi ƙarancin sifa a cikin tsarin aiki. Yawancin binciken CNS da aka buga suna ba da rahoton matsayin lakabi da kaɗan, don haka filin yana da iyaka kwatanta Shago bayanai kan nawa alamar da aka ba da ita ke canza ƙarfi ko shigar kwakwalwa don jerin da aka bayar. Bi da daidaitattun lakabi azaman zato don gwadawa, ba dukiyar gado ba.

[KYAUTA: itace yanke shawara, rassan kan ko alamar ta canza ƙarfi, narkewa, ko halin BBB, yana haifar da alamar analog, sarrafa surkulle, analog mara aiki, ko ortholog na kyauta]

Scramble, Analog mara aiki, da Tag-Free Ortholog Controls

Gina saitin sarrafawa a kusa da abin da kowane reagent ke yanke hukunci, da kuma ajiye peptide mara lakabi a cikin gwaji a duk inda mai binciken zai iya karanta shi kai tsaye.

• Sarrafa scramble (guda abun da ke ciki, tsari na bazuwar): yana ƙayyadadden sakamako masu zaman kansu irin su ɓarnawar membrane ko ɗaurin da ba na musamman ba. Ba ya sarrafa alamar sinadarai, don haka gudanar da shi tare da lakabi ɗaya idan peptide mai lakabin shine labarin gwajin ku.

• Analog mara aiki (saura m guda ɗaya maye gurbin): yana ƙetare ƙaddamar da manufa a matsayin tushen siginar. Tabbatar da canjin a zahiri yana kawar da ayyuka a cikin binciken ku maimakon ɗaukan hakan.

• Ƙwararrun ƙaƙƙarfan tag ko iyaye mara lakabi: mulkin fitar da lakabin kanta a matsayin dalilin da aka lura da tasiri. Inda karantawa yana buƙatar lakabi, Ana iya gudanar da wannan iko ne kawai a cikin lakabi mai cin gashin kansa kawai.

Babu yarjejeniya akan mafi kyawun iko guda ɗaya don gwajin CNS da aka bayar. Zaɓin ya dogara da abin da abin karantawa zai iya ganowa kuma akan ko lakabin yana ɗaukar nauyi don auna. Faɗa tunanin ku a cikin hanyoyin maimakon ambaton al'ada.

Tabbatar da sakamakon ku: siginar ya kamata ya bi tsarin aiki kuma ya ɓace tare da analog mara aiki. Idan scramble ya haifar da sakamako iri ɗaya kamar gwajin peptide, ko kuma idan masu lakabin da masu ba da alama sun bambanta, kuna da lakabi ko tasiri mai zaman kansa na jere, ba takamaiman manufa ba.

Tsarin yanke shawara: Reagent Artifact vs. Siginar Halittu

Karatun CNS wanda ke motsawa bayan jiyya na peptide yana da bayanin ɗan takara guda biyu: peptide ya yi wani abu, ko reagent ya yi. Bambance-bambancen yana da mahimmanci saboda su biyun suna buƙatar amsa sabanin ra'ayi. Wani kayan tarihi na nufin gwajin ba shi da ma'ana kuma reagent yana buƙatar sake cancanta; siginar nazarin halittu yana nufin binciken gaskiya ne kuma mataki na gaba shine aikin injina. Teburin da ke ƙasa yana yin taswirar karatun da kuka lura da shi zuwa ga reagents don yin bayaninsa, kuma ga sakamakon da zai share reagent.

Jerin Sake Gwaji Da Aka Bada Umarni

Gudanar da cak a cikin wannan tsari. Kowannensu yana kawar da takamaiman nau'in kayan tarihi, don haka gazawar da wuri tana ceton ku samfurin da lokacin matakan da zasu biyo baya zasu cinye.

1. Sake duba endotoxin tare da dawo da karu. Microglia suna jin daɗin LPS sosai, don haka kayan tarihi na farko na iya kwaikwayi wani sakamako mai kumburi na gaske. Farfadowa karu yana gaya muku ko ma'aunin ku ko matrix yana danne gwajin, wanda lambar wucewa/kasa ita kadai ba zata iya ba.

2. Sake allo don tarawa ta hanyar orthogonal. Generic hydrophobicity ya isa ya fitar da tarawa, kuma aggregates gabatar a matsayin bayyanannen iko motsi maimakon a matsayin mai tsabta mara kyau.

3. Sake tabbatar da kashi mai narkewa a cikin buffer. Tabbatar cewa peptide ya narkar da cikakke a cikin adadin da kuka sha, ba a hannun jari ba. Samuwar Peptide

4. Sake tabbatar da amincin jeri ta hanyar orthogonal. Goge peptides sune mafi girman aji mai alaƙa da ƙazanta, kuma za su iya ɗaukar wani aiki na ɓangarori waɗanda adadi mai tsafta ba zai bayyana ba.

5. Sake gudu tare da sabo mai yawa. Idan karatun ya biyo baya da yawa maimakon kashi, reagent shine mai canzawa.

Lokacin da siginar ya tsira kowane sake gwadawa

Idan tasirin ya ci gaba ta duk cak biyar, bi da shi a matsayin mafi kusantar nazarin halittu. Wannan magana ce mai yiwuwa, ba takardar shaida ba. Wasu kayan tarihi ba za a iya kawar da su gaba ɗaya ta kowane duban gefen reagent, da kuma gwajin tarawa na orthogonal kafin gwajin ya rage rashin tabbas ba tare da rufe shi ba.. Aikin tsarin shine sanya ragowar haɗarin a bayyane, don mai karatu ya san waɗanne madadin bayanin da kuka yi watsi da su da kuma waɗanda suka rage a buɗe.

Kuskure gama gari Masu Haɓaka Ƙarya

Mafi kyawun yanayin rashin nasara ba shine mummunan peptide ba. Saitin bayanai ne mai tsabta wanda aka gina akan reagent wanda bai taɓa cancanta ba, inda aka karanta kayan aikin ƙira azaman kunnawa NLRP3 kuma an ci gaba zuwa gwaji na gaba. Kurakuran benci guda huɗu masu maimaitawa suna haifar da yawancin waɗannan halayen ƙarya.

Kula da Tsaftar HPLC azaman Tabbacin Jeri

Kuskuren: karban a 95% ko 98% Siffar tsarkin HPLC azaman shaida cewa peptide shine jerin da kuka yi oda.

Me ya sa yake faruwa: HPLC ya rabu da hydrophobicity. Jerin sharewa, gutsattsakewa, ko diastereomer tare da ragowar tseren tsere guda ɗaya na iya haɗawa tare da manufa kuma har yanzu yin rijista azaman kololu mai tsabta guda ɗaya.. Tsaftar ƙima tana auna aikin rabuwa, ba tsarin aminci ba.

Gyaran: na buƙatar tabbacin MS wanda yayi daidai da ka'idar monoisotopic taro, da kuma duba filin kirgawa, saboda saura trifluoroacetate yana canzawa duka taro da halayen halitta. Inda tantancewar ke kula da saura saura guda ɗaya, nema peptide taswira ko LC-MS/MS fragmentation maimakon wani taro-kawai tabbaci.

Yin watsi da Canjin DMSO-zuwa-Buffer

Kuskuren: narkar da hannun jari na DMSO kai tsaye zuwa cikin buffer assay da ɗauka cewa ƙaddamar da ƙima shine adadin da aka bayar.

Me ya sa yake faruwa: lipophilic, jerin masu shiga kwakwalwa suna da iyakacin narkewar ruwa. A iyakar DMSO-zuwa-buffer suna iya faɗuwa, kuma sakamakon turbidity sau da yawa ana karanta a matsayin m assay hayaniyar maimakon kamar yadda batattu Analyte.

Gyaran: gudanar da dilution a CSF-mimetic buffer, duba ga turbidity ko particulate a karshe taro, kuma tabbatar da juzu'in mai narkewa kafin sanya kashi. Idan mafita ba ta bayyana ba, ainihin maida hankali yana ƙasa da ƙima ba tare da la'akari da abin da lissafin ya faɗi ba.

Bayar da rahoton Endotoxin azaman Pass/Fail

Kuskuren: rikodin endotoxin a matsayin "wuce ƙayyadaddun bayanai" da ci gaba.

Me ya sa yake faruwa: An rubuta takaddun shaida-saki don yanke shawarar saki, ba don ƙirar ƙima ba. Bayanin wucewa/ gazawa ba ya ɗauke da ƙima mai ɗaure ɗaya, don haka ba za a iya jujjuya shi zuwa mahimmin tattarawa ba.

Gyaran: nemi sakamakon a cikin EU/MG ko EU/ml, daura da samfurin da aka gwada, tare da rubuce-rubucen dawo da karu. Sa'an nan kuma ƙididdige abin da adadin peptide ke ba da gudummawa a lokacin aikin ku. Yawancin da ke wuce sakin har yanzu na iya isar da siginar TLR4 mai ruɗani a babban adadin micromolar.

Sake Amfani da Hannun Daskare-Thawed

Kuskuren: fitar da aliquot iri ɗaya daga cikin injin daskarewa don kowane maimaitawa a cikin nazarin makonni da yawa.

Me ya sa yake faruwa: Ana kula da hawan keken daskarewa a matsayin mara lahani ga peptide “tsayayyen”, kuma aliquoting-amfani guda ɗaya yana kama da aikin da ba dole ba.

Gyaran: aliquot da farko sake gyara kuma jefar bayan amfani daya. Samuwar barbashi yana taruwa a cikin zagayawa, kuma jimlar juzu'i shine ainihin nau'in da ya fi dacewa ya fitar da abin karantawa mai kumburi. Lura da iyaka a nan: littattafan daskare-narke an gina su ne akan jarin furotin, ba peptides, kuma babu iyaka zagaye na duniya da ya shafi. Yi la'akari da adadin zagayowar azaman mai canzawa da kuke sarrafawa kuma ku rubuta, ba kofa ba za ka iya duba sama.

Tabbatar da Sakamakonku: Wuraren Cancanci

An gama cancanta lokacin da za ku iya mika wa mai bita takamaiman rikodi guda ɗaya mai ɗauke da duk abubuwa shida da ke ƙasa. Kowanne yana iya tabbatarwa akan takarda, ba memowa abin da dillalin ya fada a wayar ba.

• Shaida: Tabbataccen ƙwayar ƙwayar cuta ta MS wanda yayi daidai da jerin da kuka yi oda, tare da duba kothogonal (peptide taswira ko LC-MS/MS) duk inda jerin ko gyara ya bada garantin daya.

• Tari: sharertaccen sakamakon allo a maida hankalin ku na aiki, tare da hanyar da maida hankali da aka rubuta.

• Solubility: daftarin kashi mai narkewa a cikin buffer na CSF-mimetic, gami da kashi na DMSO na ƙarshe.

• Endotoxin: sakamako mai ɗaure (EU/mg ko EU/ml) tare da farfadowar karu wanda ke tabbatar da ƙima a cikin matrix ɗin ku.

• Sarrafa: ƙayyadaddun saitin ɓarna, analog mara aiki, da kuma reagents na ortholog na kyauta, kowanne ya cancanci daidai daidai da peptide gwajin.

• Abun iya ganowa: lambar da yawa, ranar saki, da kunshin nazari wanda ya danganta kowane filin da ke sama da wannan kuri'a.

Manufar mikewa ita ce a tsawaita wannan daga rikodin kowane-wuri zuwa cikin rajistar cancantar matakin matakin karatu: jere daya a kowace kuri'a, shafi ɗaya a kowane wurin bincike, don haka binciken watanni da yawa na iya nunawa a kallo cewa kowane rukuni ya shiga gwajin a ƙarƙashin sharuɗɗan cancanta iri ɗaya..

[KYAUTA: kafin-bayan, bangaren hagu yana nuna Mataki 1 jihar (a CoA tare da tsafta kashi kuma babu wani abu); sashin dama yana nuna cikakken rikodin tare da ainihi, tarawa, narkewa, endotoxin, sarrafawa, kuma an cika filayen ganowa]

Idan kuna son a ba da wannan rikodin maimakon haɗawa, Nemi fakitin nazari na musamman don jerin da kuke gudana, ko buɗe tattaunawa ta fasaha akan al'ada ko gyare-gyaren buƙatun peptide. Canje-canje na MOL yana bugawa azaman mai siyar da peptide kuma yana da sha'awar kasuwanci cikin ƙa'idodin ingancin peptide; wuraren binciken da ke sama iri ɗaya ne da za mu sa ran mai bita ya yi amfani da mu.

Reviewed by [Suna], Ph.D., Nazari Chemistry.

Samun ingancin peptide reagent don binciken NLRP3 mai shiga kwakwalwa zuwa ma'auni mai karewa shine aikin tattara bayanai gwargwadon nazari.: masu tantancewa suna gaya muku abin da ke cikin vial, kuma rikodin shine abin da zai bari wani ya tabbatar da shi.

Tambayoyin da ake yawan yi

Yaya tsawon lokacin cancantar peptide reagent ke ɗauka?

Tsara sati biyu zuwa hudu daga rasidin kuri'a zuwa rikodin cancantar sa hannu. Masu canji uku suna motsa wannan taga: ko ana buƙatar hanyoyin jeri na orthogonal kamar taswirar peptide ko LC-MS/MS, ko gwajin endotoxin yana gudana a cikin gida ko zuwa dakin gwaje-gwajen kwangila, kuma ko sabo ne sai an samu. Idan kuri'a ta zo tare da cikakken kunshin nazari da iyawar endotoxin na cikin gida, aikin yana matsawa zuwa ƙananan ƙarshen.

Zan iya musanya ƙaramin ƙwayar NLRP3 mai hanawa a matsayin ingantaccen iko?

Sai kawai a matsayin sarrafa magunguna, ba a matsayin madadin cancantar reagent ba. Babban wallafe-wallafen ya ƙunshi ƙananan ƙwayoyin NLRP3 inhibitors, don haka suna da kyau a san su don haɗin kai, amma ba su gaya muku kome ba game da ko peptide reagent na ku yana nuna hali. Gudu biyu: ƙananan kwayoyin halitta ya tabbatar da amsawa, kuma kuri'a na peptide ya tabbatar da cewa reagent naka yana da tsabta.

Me zan yi idan peptide dina ya gaza a allon haɗakarwa?

Sake tace ko saka hannun jari, sannan a sake duba maida hankali kafin a dauka cewa kuri'a ba ta da amfani. A 0.22 Matakin tacewa µm yana share abubuwan da suka rigaya sun kasance, amma dole ne ku sake auna maida hankali bayan haka saboda abu ya ɓace akan tacewa. Idan samfurin har yanzu ya tara, daidaita ƙimar canjin DMSO-zuwa-buffer ko buƙatar wani yawa daban.

Shin peptide mai lakabin karbabbe ne ga reagent mara lakabi?

Ya dogara da ko alamar ta canza ƙarfi, narkewa, ko halayen shingen kwakwalwar jini. Fluorophore ko tag na iya canzawa duka ukun, don haka siffata alamar analog ɗin daban maimakon ɗaukar daidaito. Yi amfani da peptide mai lakabin don ganowa da kuma reagent mara lakabi don karatun farko.

Ta yaya zan cancanci peptide don binciken da ya fi tsayi fiye da ɗaya?

Yi rikodin lambar kuri'a a farkon karatu, sannan ku cancanci kowane sabon kuri'a akan wuraren bincike iri ɗaya da kuka yi amfani da su a farko. Gada kuri'a ta hanyar gudanar da kwatancen gefe-da-gefe akan farantin gwaji guda ɗaya kafin canzawa. Yi rikodin kowane canji na tsakiyar karatu, gami da bayanan cancanta, don haka ana iya gano maɓalli a cikin rikodin.